Results 51 to 60 of about 3,609 (205)
Primers, crRNAs and chemically synthesized CCHFV RNA fragments.
Primers, crRNAs and chemically synthesized CCHFV RNA fragments.
Greg Smith (343139) +5 more
core +1 more source
Field vaccination against CCHFV and Hyalomma tick infestation reduces multiple tick-borne infections in sheep. [PDF]
Abstract Tick-borne pathogens (TBPs) are expanding globally, with their impact on public health expected to rise due to climate change. Immunizing livestock offers a cost-effective alternative or adjunct to human vaccination. We evaluated two DNA vaccines, one targeting Crimean-Congo hemorrhagic fever virus (CCHFV)
Mhamadi M +17 more
europepmc +3 more sources
Tick‐Tac‐Foe: When Ticks, Trade, and Zoonotic Pathogens Align in African Wet Meat Markets
ABSTRACT Zoonotic diseases account for over ∼60% of infectious diseases and present a significantly growing fatality threat in Africa. Live and wet markets (LWMs) in Africa function as key economic venues that support human livelihoods through social interaction and trade in food stuff, including meat and other animal‐based products.
Allen Takudzwa Munaro
wiley +1 more source
Longitudinal seroprevalence of Crimean-Congo hemorrhagic fever virus in Southern Uganda
Crimean-Congo hemorrhagic fever (CCHF) is a tick-borne disease endemic to many regions of Africa, the Middle East, Southeast Asia and the Balkans. Caused by the CCHF virus (CCHFV), CCHF has been a recognized cause of illness in Uganda since the 1950s and
Evan A. Mihalakakos +14 more
doaj +1 more source
Mapping of Antibody Epitopes on the Crimean-Congo Hemorrhagic Fever Virus Nucleoprotein
Crimean-Congo hemorrhagic fever virus (CCHFV), a nairovirus, is a tick-borne zoonotic virus that causes hemorrhagic fever in humans. The CCHFV nucleoprotein (NP) is the antigen most used for serological screening of CCHFV infection in animals and humans.
Boniface Pongombo Lombe +9 more
doaj +1 more source
Potential entry pathways for 25 vector‐borne disease agents
Abstract This Scientific Report identifies the potential entry pathways for 25 selected vector‐borne diseases (VBDs) into currently free EU Member States. The diseases comprise 12 listed under the Animal Health Law (AHL) and 13 non‐listed diseases, selected using predefined eligibility criteria.
European Food Safety Authority (EFSA) +7 more
wiley +1 more source
Sensitivity and permissivity to CCHFV and DUGV.
(A) CCHFV- and DUGV-infected cells were assayed for the cell supernatant titres, using a specific polyclonal antibody, expressed in FFU/ml; (B) the percentage of CCHFV-infected cells, calculated using the fluorescent photomicrography and analysed using ...
Guy Vernet (174407) +3 more
core +1 more source
Knowledge mapping of risk mitigation measures against vector‐borne diseases
Abstract A comprehensive synthesis of current evidence on surveillance, prevention and control measures for 25 selected vector‐borne diseases (VBDs) affecting animals in the EU is presented here. The assessment integrates evidence from systematic literature reviews, modelling studies, field investigations and expert judgement.
European Food Safety Authority (EFSA) +8 more
wiley +1 more source
CCHFV effects and expression in Huh7 cell line.
(A) Optical photomicrography of CCHFV-infected Huh7 monolayers at MOIs 0.1 and 1. Observations were performed from 48 to 120 h p.i.: on the left are represented mock-infected cells (M) and UV-inactivated CCHFV-infected cells (i); on the center CCHFV ...
Guy Vernet (174407) +3 more
core +1 more source
Background Crimean-Congo Hemorrhagic Fever (CCHF) is a fatal infection, but no clinical case due to AP92 strain was reported. We described the first clinical case due to AP92 like CCHFV.
Midilli Kenan +8 more
doaj +1 more source

